focus -WSS

focus

author：explore 2025-09-30 16:26:41 - browse：1832

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： STAT Executive Editor Rick Berke on STAT's 8th birthday

WSS

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Involuntary treatment for addiction doesn't work

The Sacklers, horror, and ‘The Fall of the House of Usher’

Why police arrested suspected Gilgo Beach killer away from his house

Free speech concerns arise in wake of journal editor Eisen's firing

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

hotspot

focus

Wikipedia

Medical records are filled with copy

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Grail faces three suits alleging harassment, retaliation

Peter Hotez and the public health issue of online harassment

Biotech incubator Curie.Bio graduates its first startup

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Eli Lilly to acquire Versanis in heated race for weight loss drugs

The cancer drug shortage isn’t new — and neither are the solutions

Senate panel clears PBM, hopsital reforms

Wikipedia

HPV cancer vaccine study demonstrates efficacy

Abortion clinic in Cancun will cater to Americans

Does aspartame cause cancer? What new WHO guidance says

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Just how powerful is the placebo effect?

STAT Executive Editor Rick Berke on STAT's 8th birthday

hotspot

leisure time

hotspot

Wikipedia